SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ESTECH Announces FDA Approval to Begin Enrollment in ATTAC-AF IDE Trial for the Treatment of Atrial Fibrillation During Cardiac Surgery